Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Schrijver LH, Antoniou AC, Olsson H, Mooij TM, Roos-Blom MJ, Azarang L, Adlard J, Ahmed M, Barrowdale D, Davidson R, Donaldson A, Eeles R, Evans DG, Frost D, Henderson A, Izatt L, Ong KR, Bonadona V, Coupier I, Faivre L, Fricker JP, Gesta P, van Engelen K, Jager A, Menko FH, Mourits MJE, Singer CF, Tan YY, Foretova L, Navratilova M, Schmutzler RK, Ellberg C, Gerdes AM, Caldes T, Simard J, Olah E, Jakubowska A, Rantala J, Osorio A, Hopper JL, Phillips KA, Milne RL, Beth Terry M, Noguès C, Engel C, Kast K, Goldgar DE, van Leeuwen FE, Easton DF, Andrieu N, Rookus MA; Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study. Schrijver LH, et al. Among authors: mooij tm. Am J Obstet Gynecol. 2021 Jul;225(1):51.e1-51.e17. doi: 10.1016/j.ajog.2021.01.014. Epub 2021 Jan 22. Am J Obstet Gynecol. 2021. PMID: 33493488 Free PMC article.
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
Hermsen BB, Olivier RI, Verheijen RH, van Beurden M, de Hullu JA, Massuger LF, Burger CW, Brekelmans CT, Mourits MJ, de Bock GH, Gaarenstroom KN, van Boven HH, Mooij TM, Rookus MA. Hermsen BB, et al. Among authors: mooij tm. Br J Cancer. 2007 May 7;96(9):1335-42. doi: 10.1038/sj.bjc.6603725. Epub 2007 Apr 10. Br J Cancer. 2007. PMID: 17426707 Free PMC article.
Maternal death related to IVF in the Netherlands 1984-2008.
Braat DD, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE. Braat DD, et al. Among authors: mooij tm. Hum Reprod. 2010 Jul;25(7):1782-6. doi: 10.1093/humrep/deq080. Epub 2010 May 19. Hum Reprod. 2010. PMID: 20488805
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.
van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW. van Leeuwen FE, et al. Among authors: mooij tm. Hum Reprod. 2011 Dec;26(12):3456-65. doi: 10.1093/humrep/der322. Epub 2011 Oct 26. Hum Reprod. 2011. PMID: 22031719 Free PMC article.
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Collée JM, Jansen L, Kets CM, Keymeulen KB, Koppert LB, Meijers-Heijboer HE, Mooij TM, Tollenaar RA, Vasen HF; HEBON; Hooning MJ, Seynaeve C. Heemskerk-Gerritsen BA, et al. Among authors: mooij tm. Int J Cancer. 2015 Feb 1;136(3):668-77. doi: 10.1002/ijc.29032. Epub 2014 Jul 8. Int J Cancer. 2015. PMID: 24947112 Free article.
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment data.
Krul IM, Groeneveld E, Spaan M, van den Belt-Dusebout AW, Mooij TM, Hauptmann M, Twisk JW, Lambers MJ, Hompes PG, Burger CW, Lambalk CB, van Leeuwen FE; OMEGA-project group. Krul IM, et al. Among authors: mooij tm. Eur J Cancer. 2015 Jan;51(1):112-20. doi: 10.1016/j.ejca.2014.10.018. Epub 2014 Nov 25. Eur J Cancer. 2015. PMID: 25466508
Melanoma risk after ovarian stimulation for in vitro fertilization.
Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, van Leeuwen FE; OMEGA-project group. Spaan M, et al. Among authors: mooij tm. Hum Reprod. 2015 May;30(5):1216-28. doi: 10.1093/humrep/dev023. Epub 2015 Mar 4. Hum Reprod. 2015. PMID: 25743782
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?
van Tilborg TC, Broekmans FJ, Pijpe A, Schrijver LH, Mooij TM, Oosterwijk JC, Verhoef S, Gómez Garcia EB, van Zelst-Stams WA, Adank MA, van Asperen CJ, van Doorn HC, van Os TA, Bos AM, Rookus MA, Ausems MG. van Tilborg TC, et al. Among authors: mooij tm. Menopause. 2016 Aug;23(8):903-10. doi: 10.1097/GME.0000000000000633. Menopause. 2016. PMID: 27326821
32 results